Weinan Xue

448 total citations
17 papers, 309 citations indexed

About

Weinan Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weinan Xue has authored 17 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Weinan Xue's work include Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers) and Genetic factors in colorectal cancer (4 papers). Weinan Xue is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers) and Genetic factors in colorectal cancer (4 papers). Weinan Xue collaborates with scholars based in China and United States. Weinan Xue's co-authors include Peng Han, Mingqi Li, Yanlong Liu, Di Wu, Jinxue Tong, Xin Li, Fan Wang, Yanlong Liu, Binbin Cui and Jingwen Li and has published in prestigious journals such as Frontiers in Immunology, Cell Death and Disease and Oncotarget.

In The Last Decade

Weinan Xue

17 papers receiving 303 citations

Peers

Weinan Xue
Shunsuke Misono Japan
Runyi Ye China
Donna K. Dang United States
Hanna E. Rauhala Finland
Yaqi Gan China
Namrata Bhatnagar United States
Xiaochuang Feng China
Shu‐Hsuan Liu Taiwan
Dongkui Gong China
Subhasree Balakrishnan United States
Shunsuke Misono Japan
Weinan Xue
Citations per year, relative to Weinan Xue Weinan Xue (= 1×) peers Shunsuke Misono

Countries citing papers authored by Weinan Xue

Since Specialization
Citations

This map shows the geographic impact of Weinan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weinan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weinan Xue more than expected).

Fields of papers citing papers by Weinan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weinan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weinan Xue. The network helps show where Weinan Xue may publish in the future.

Co-authorship network of co-authors of Weinan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Weinan Xue. A scholar is included among the top collaborators of Weinan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weinan Xue. Weinan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xi, Caixia, Junfeng Pang, Weinan Xue, et al.. (2025). Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice. Communications Biology. 8(1). 15–15. 2 indexed citations
2.
Hawsawi, Ohuod, Weinan Xue, Tingting Du, et al.. (2025). Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth. Cell Reports Medicine. 6(1). 101890–101890. 2 indexed citations
3.
Xia, Tianyi, et al.. (2022). A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer. Frontiers in Bioengineering and Biotechnology. 10. 862619–862619. 3 indexed citations
4.
Liu, Yupeng, Qiuju Zhang, Chao Yuan, et al.. (2022). Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA. Frontiers in Oncology. 11. 758509–758509. 13 indexed citations
5.
6.
Zeng, Furong, Huiyan Sun, Yanlong Liu, et al.. (2022). Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients. Bioengineered. 13(2). 2498–2512. 38 indexed citations
7.
8.
Xue, Weinan, Nannan Zhang, Junde Zhou, et al.. (2020). <p>Differential Metabolic Alterations and Biomarkers Between Gastric Cancer and Colorectal Cancer: A Systematic Review and Meta-Analysis</p>. OncoTargets and Therapy. Volume 13. 6093–6108. 16 indexed citations
9.
Xue, Weinan, Fan Wang, Peng Han, et al.. (2020). The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2. Aging. 12(20). 20396–20412. 14 indexed citations
10.
Wu, Di, et al.. (2019). Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7. Cell Death and Disease. 10(7). 514–514. 80 indexed citations
11.
Jiang, Yang, et al.. (2019). SPNS2 promotes the malignancy of colorectal cancer cells via regulating Akt and ERK pathway. Clinical and Experimental Pharmacology and Physiology. 46(9). 861–871. 26 indexed citations
12.
Xue, Weinan, et al.. (2018). Genome-wide methylation analysis identifies novel prognostic methylation markers in colon adenocarcinoma. Biomedicine & Pharmacotherapy. 108. 288–296. 13 indexed citations
13.
Xue, Weinan, Jingwen Li, Fan Wang, et al.. (2017). A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma. Oncotarget. 8(60). 101298–101308. 20 indexed citations
14.
Li, Jingwen, et al.. (2017). Identification of potential long non-coding RNA biomarkers associated with the progression of colon cancer. Oncotarget. 8(44). 75834–75843. 17 indexed citations
15.
Jia, Yunhe, Wenjing Tian, Shuai Sun, et al.. (2013). The influence of genetic polymorphisms in MDR1 gene on breast cancer risk factors in Chinese. Medical Oncology. 30(3). 601–601. 6 indexed citations
16.
Han, Jiguang, Yongdong Jiang, Chunhui Zhang, et al.. (2011). Clinicopathologic characteristics and prognosis of young patients with breast cancer. The Breast. 20(4). 370–372. 18 indexed citations
17.
Pang, Da, Yashuang Zhao, Weinan Xue, et al.. (2011). Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese. Medical Oncology. 29(3). 1561–1568. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunsuke Misono Breakdown of academic impact, for papers by Runyi Ye Breakdown of academic impact, for papers by Donna K. Dang Breakdown of academic impact, for papers by Hanna E. Rauhala Breakdown of academic impact, for papers by Yaqi Gan Breakdown of academic impact, for papers by Namrata Bhatnagar Breakdown of academic impact, for papers by Xiaochuang Feng Breakdown of academic impact, for papers by Shu‐Hsuan Liu Breakdown of academic impact, for papers by Dongkui Gong Breakdown of academic impact, for papers by Subhasree Balakrishnan
Rankless by CCL
2026